Reverse Capitalization (Tables)

12 Months Ended

Dec. 31, 2024

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

Schedule of Merge Allocated of Consolidated Statements of Operations

The following table summarizes the elements of the merger allocated to the Consolidated Statements of Changes in Stockholder’s Equity:

	Amounts
Cash: OLIT trust	$	3,167,479
Cash: OLIT		45,946
Gross Proceeds		3,213,425
Net liabilities assumed in merger transaction		(158,404	)
OLIT transaction costs paid at close		(1,365,000	)
Net benefit assumed in recapitalization	$	1,690,021

	Number of Shares
Common stock, outstanding prior to merger		1,348,049
Less: Redemption of OLIT shares		(1,051,450	)
OLIT Public Shares		296,599
OLIT Sponsor Shares		4,791,667
Legacy Syntec shares (1)		31,600,000
Total shares of common stock immediately after the merger		36,688,266

(1) - The number of Legacy Syntec shares was determined from the shares of Legacy Syntec outstanding immediately prior to the closing of the merger converted at The Exchange Ratio. All fractional shares were rounded down.